00:00:00 IGIHE NETWORK KN KINYARWANDA EN ENGLISH FR FRANCAIS

Umuti wa Remdesivir ugabanya ibyago byo kwicwa na COVID-19 ku kigero cya 30%

Yanditswe na Ishimwe Alain
Kuya 12 October 2020 saa 05:16
Yasuwe :

Ikigo cy’Abanyamerika gikora Ubushakashatsi ku Buzima, National Institute of Health, cyagaragaje ko umuti wa Remdesivir usanzwe ukoreshwa mu kuvura COVID-19, ugabanya impfu z’abahitanwa n’iki cyorezo ku kigero cya 30% ugereranyije n’indi miti ikoreshwa mu kuvura abacyanduye.

Inzobere zakoze ubu bushakashatsi zagereranyije abarwayi ba Coronavirus bahabwa umuti ugabanya ubukana wa Remdesivir no kubahabwa uwitwa Placebo.

Ubushakashatsi bwagaragaje ko abahawe umuti wa Remdesivir bakize mu gihe kitarenze iminsi icumi ugereranyije n’abahabwa umuti wa Placebo bashobora gukira nyuma y’iminsi 15.

Remdesivir ifunga imisemburo ifasha Coronavirus kwiremamo uduce twinshi, uyu muti kandi utuma iyi virus itabasha gukwirakwira mu mubiri.

Umwe mu nzobere zari zigize itsinda ryakoze ubu bushakashatsi, Dr. John Beigel, yatangarije Daily Mail ko umuti wa Remdesivir ari wo ufasha abarwayi ba Coronavirus gukira byihuse.

Nk’uko ubushakashatsi bwabigaragaje mu barwayi bakiriwe bari ku rwego rwo kongererwa umwuka bahawe umuti wa Remdesivir babashije gukira mu minsi 15 mu gihe abahawe umuti wa Placebo bakize nyuma y’iminsi 21.

Ubu bushakasatsi bwagaragaje ko byibuze abarwayi 11% aribo bicwa na COVID-19 barahawe umuti wa Remdesivir mu gihe 15% aribo bapfa bavurwa hakoreshejwe Placebo. Ibi byagaragaje ko umuti wa Remdesivir ugabanya ikigero cyo gupfa ku ijanisha rya 30%.

Ubwo hakorwaga ubu bushakashatsi kandi byagaragaye ko uyu muti ushobora guhagarika virusi zo mu bwoko bwa SARS na MERS zose ziri mu muryango umwe na virusi ya Corona.

Kuri ubu Remdesivir ni wo muti uri kwifashishwa mu guhangana na COVID-19 muri Leta Zunze Ubumwe za Amerika.

Umuti wa Remdesivir ugabanya ibyago byo kwicwa na COVID-19 ku kigero cya 30%

Kwamamaza

Kwamamaza

Kwamamaza

TANGA IGITEKEREZO

AMATEGEKO AGENGA IYANDIKA RY'IGITEKEREZO CYAWE
Kwamamaza

Special pages
. . . . . .